Your doctor pointed out a rough, scaly patch on your face or scalp and called it an actinic keratosis. It is easy to feel uneasy when you hear that a spot is "precancerous." The good news: actinic keratosis is common, very treatable, and there are several proven options to clear it.
This guide walks you through how actinic keratosis is treated, what each option feels like, and how to know when a spot needs a dermatologist's attention.
How is actinic keratosis treated?
Actinic keratosis treatment falls into two broad approaches. Lesion-directed treatments target individual spots one at a time. Field-directed treatments treat a whole zone of sun-damaged skin, including the visible lesions and the normal-looking skin around them, because more damage is often present than you can see.
Because it is hard to predict which actinic keratoses might progress, doctors usually treat them as a precaution rather than waiting and watching. Your dermatologist will pick an approach based on how many lesions you have, where they are, and your overall skin health.
- Lesion-directed: cryotherapy (freezing), curettage (scraping), and laser ablation for individual spots
- Field-directed: prescription creams and gels, photodynamic therapy, chemical peels, and fractional laser resurfacing for broader areas
- Field therapy is most effective on the face and is useful when you have multiple lesions clustered together
Cryotherapy: the most common treatment
Cryotherapy with liquid nitrogen is the most commonly used treatment for actinic keratosis in the United States. In the office, your clinician applies the liquid nitrogen to each spot for a few minutes. The frozen skin typically blisters and then peels off over the following days as healthy skin grows underneath.
Cryotherapy works well for single or scattered lesions. According to the American Academy of Dermatology, a double-freeze-thaw technique clears roughly 76 to 88 percent of treated lesions at 3 months, with overall clearance of about 35 to 51 percent at around 5 months. Mild stinging, redness, and a small blister at the treated site are normal afterward.
Prescription creams and gels (field therapy)
When you have many lesions or widespread sun damage, a prescriber may choose a topical medication you apply at home over several weeks. These creams and gels treat the whole field of affected skin. Most cause a temporary local reaction, such as redness, scaling, or crusting, as they work, which can look alarming but usually signals the treatment is doing its job.
Common prescription options include fluorouracil (an antimetabolite), imiquimod (an immune modulator), and diclofenac (an anti-inflammatory). Newer field therapies such as tirbanibulin and ingenol mebutate are designed for limited areas, up to about 25 square centimeters on the face, scalp, and forearms. Pretreating with a keratolytic like urea, salicylic acid, or a topical retinoid can improve how well these medicines penetrate.
- Fluorouracil (Carac, Efudex): antimetabolite cream
- Imiquimod (Aldara, Zyclara): immune-modulating cream; the 5% formulation is FDA-approved for a regimen of one packet applied twice weekly to a 25 cm2 area for 16 weeks
- Diclofenac gel: gentler, with little of the inflammatory reaction seen with other field treatments
- Tirbanibulin and ingenol mebutate: short-course field therapies for small areas
Which treatment clears actinic keratosis best?
No single treatment is right for everyone. A large Cochrane systematic review pooled 83 randomized controlled trials of 24 treatments across more than 10,000 participants and found that results vary by drug, lesion, and location.
In one comparative analysis, complete clinical clearance was higher for 5-fluorouracil combined with salicylic acid (about 55 percent) than for ingenol mebutate (about 42 percent) or imiquimod (roughly 25 to 36 percent). Lesion-directed cryotherapy is excellent at clearing the spots you can see and relieving symptoms, while field-directed topical therapy may do more to prevent the underlying damage from progressing. Your dermatologist can weigh these trade-offs for your specific situation.
Why treating actinic keratosis matters
Actinic keratosis is considered an early phase of squamous cell carcinoma, a type of skin cancer. While many individual lesions never become cancer, and roughly 23 percent regress on their own, having multiple lesions lowers the odds of spontaneous regression and raises cumulative risk over time.
The numbers explain why doctors take these spots seriously: up to 65 percent of cutaneous squamous cell carcinomas arise from pre-existing actinic keratoses, and the per-patient 10-year risk of an actinic keratosis transforming into invasive cancer is estimated at about 6 to 10 percent. Treating the spots, and the field around them, is a practical way to reduce that risk.
When to see a doctor
Any new, persistent rough or scaly patch on sun-exposed skin deserves a professional look, especially if you are over 45, have fair skin, work outdoors, or have a history of skin cancer. Diagnosis is usually a simple visual exam, with a skin biopsy only if there is doubt.
See a dermatologist promptly if a spot grows quickly, bleeds, becomes tender, develops a sore that will not heal, or changes in a way that worries you. These can be signs a lesion has progressed and needs evaluation. After treatment, annual skin checks are recommended so any new or recurring spots are caught early. If you want a convenient starting point, a clinician-overseen tool like Nolla can help you understand a spot and connect you to care, but anything suspicious should be examined in person.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any new skincare treatment, especially if you have underlying health conditions, are pregnant, or are taking medications.
